Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Short-term Investments (2016 - 2017)

Historic Short-term Investments for Palisade Bio (PALI) over the last 4 years, with Q4 2017 value amounting to $5.0 million.

  • Palisade Bio's Short-term Investments changed 0.0% to $5.0 million in Q4 2017 from the same period last year, while for Dec 2017 it was $5.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $5.0 million for FY2017, which is 0.0% changed from last year.
  • According to the latest figures from Q4 2017, Palisade Bio's Short-term Investments is $5.0 million, which was down 0.0% from $5.0 million recorded in Q3 2017.
  • Palisade Bio's Short-term Investments' 5-year high stood at $15.0 million during Q1 2015, with a 5-year trough of $5.0 million in Q4 2016.
  • Over the past 4 years, Palisade Bio's median Short-term Investments value was $7.5 million (recorded in 2015), while the average stood at $9.8 million.
  • The largest annual percentage gain for Palisade Bio's Short-term Investments in the last 5 years was 21.61% (2015), contrasted with its biggest fall of 6656.7% (2015).
  • Over the past 4 years, Palisade Bio's Short-term Investments (Quarter) stood at $15.0 million in 2014, then tumbled by 49.91% to $7.5 million in 2015, then tumbled by 33.49% to $5.0 million in 2016, then changed by 0.0% to $5.0 million in 2017.
  • Its last three reported values are $5.0 million in Q4 2017, $5.0 million for Q3 2017, and $5.0 million during Q2 2017.